Medindia

X

2-Drug Combo Retards Advanced Pancreatic Cancer: Mayo Clinic-Led Study

by Nancy Needhima on  April 4, 2012 at 1:05 PM Cancer News   - G J E 4
Combining novel drug TH-302 with the standard drug gemcitabine reveals early signs of delaying the worsening of cancer in patients with advanced pancreatic cancer discovered a Mayo Clinic-led study. This was evaluated using a measure termed progression-free survival (PFS). According to the results of a multi-center Phase II clinical trial, patients receiving the combination of gemcitabine and TH-302 demonstrated a progression-free survival of 5.6 months compared to 3.6 months in those patients who received gemcitabine alone.
2-Drug Combo Retards Advanced Pancreatic Cancer: Mayo Clinic-Led Study
2-Drug Combo Retards Advanced Pancreatic Cancer: Mayo Clinic-Led Study
Advertisement

The two-month delay in worsening of the cancer is considered significant given that the average survival of patients with advanced pancreatic cancer is only six to seven months.

Advertisement
Lead researcher Mitesh Borad, M.D., of Mayo Clinic in Arizona, will present the results of the Phase II study on Monday, April 2, at the American Association for Cancer Research (AACR) Annual Meeting.

The scientific basis of using TH-302 is to target low-oxygen (hypoxic) areas in cancers that are a common source of drug resistance to conventional chemotherapy drugs. Promising results of the combination of TH-302 and gemcitabine in pancreatic cancer animal models preceded this clinical trial in patients.

The Phase II clinical trial included 214 patients from June 2010 to June 2011 at 45 centers. Patients were randomized to receive standard therapy with gemcitabine or gemcitabine in combination with one of two doses of TH-302.

"The results of the trial support ongoing study of TH-302 in pancreatic cancer," Dr. Borad says.

Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All